Nanoscale amphiphilic macromolecules as lipoprotein inhibitors: the role of charge and architecture
暂无分享,去创建一个
[1] J. Benoit,et al. Evaluation of pegylated lipid nanocapsules versus complement system activation and macrophage uptake. , 2006, Journal of biomedical materials research. Part A.
[2] K. Uhrich,et al. Novel amphiphilic macromolecules and their in vitro characterization as stabilized micellar drug delivery systems. , 2006, Journal of colloid and interface science.
[3] P. Moghe,et al. Engineered polymeric nanoparticles for receptor-targeted blockage of oxidized low density lipoprotein uptake and atherogenesis in macrophages. , 2006, Biomacromolecules.
[4] P. Wolf,et al. Heart disease and stroke statistics--2006 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. , 2006, Circulation.
[5] P. Moghe,et al. Nanoscale anionic macromolecules can inhibit cellular uptake of differentially oxidized LDL. , 2006, Biomacromolecules.
[6] S. Ramakrishna,et al. Fabrication of collagen-coated biodegradable polymer nanofiber mesh and its potential for endothelial cells growth. , 2005, Biomaterials.
[7] S. Ramakrishna,et al. Fabrication and endothelialization of collagen-blended biodegradable polymer nanofibers: potential vascular graft for blood vessel tissue engineering. , 2005, Tissue engineering.
[8] T. Malinski. Understanding nitric oxide physiology in the heart: a nanomedical approach. , 2005, The American journal of cardiology.
[9] Wei He,et al. Grafting of gelatin on electrospun poly(caprolactone) nanofibers to improve endothelial cell spreading and proliferation and to control cell Orientation. , 2005, Tissue engineering.
[10] J. Meng,et al. Improving the blood compatibility of polyurethane using carbon nanotubes as fillers and its implications to cardiovascular surgery. , 2005, Journal of biomedical materials research. Part A.
[11] G. Velasco-Loyden,et al. Control of scavenger receptor-mediated endocytosis by novel ligands of different length , 2005, Molecular and Cellular Biochemistry.
[12] Stephan Marsch,et al. Cell targeting by a generic receptor-targeted polymer nanocontainer platform. , 2005, Journal of controlled release : official journal of the Controlled Release Society.
[13] F. Nakajima,et al. 2,4‐Bis(octadecanoylamino)benzenesulfonic Acid Sodium Salt as a Novel Scavenger Receptor Inhibitor with Low Molecular Weight. , 2004 .
[14] Isabelle Raynal,et al. Macrophage Endocytosis of Superparamagnetic Iron Oxide Nanoparticles: Mechanisms and Comparison of Ferumoxides and Ferumoxtran-10 , 2004, Investigative radiology.
[15] J Szebeni,et al. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.
[16] S. Volinia,et al. Nanotechnologies and microchips in genetic diseases. , 2003, Journal of nephrology.
[17] G. Bondjers,et al. The extracellular matrix on atherogenesis and diabetes-associated vascular disease. , 2002, Atherosclerosis. Supplements.
[18] J. Moses,et al. Glycosaminoglycan-lipoprotein interaction , 2001, Glycoconjugate Journal.
[19] S. Gordon,et al. Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The mouse's tale. , 2001, The Journal of clinical investigation.
[20] A. Chait,et al. Oxidized LDL bind to nonproteoglycan components of smooth muscle extracellular matrices. , 2001, Journal of lipid research.
[21] H. Jo,et al. Cell signaling by reactive nitrogen and oxygen species in atherosclerosis. , 2000, Free radical biology & medicine.
[22] A. Annila,et al. Oxidation of Low Density Lipoprotein Particles Decreases Their Ability to Bind to Human Aortic Proteoglycans , 1997, The Journal of Biological Chemistry.
[23] Daniel Steinberg,et al. Low Density Lipoprotein Oxidation and Its Pathobiological Significance* , 1997, The Journal of Biological Chemistry.
[24] K. Williams,et al. The response-to-retention hypothesis of early atherogenesis. , 1995, Arteriosclerosis, thrombosis, and vascular biology.
[25] M. Krieger,et al. Molecular flypaper, host defense, and atherosclerosis. Structure, binding properties, and functions of macrophage scavenger receptors. , 1993, The Journal of biological chemistry.
[26] M. Traber,et al. Receptor activities for low-density lipoprotein and acetylated low- density lipoprotein in a mouse macrophage cell line (IC21) and in human monocyte-derived macrophages , 1981, The Journal of experimental medicine.
[27] Y. Kim,et al. Thrombogenicity and blood coagulation of a microcatheter prepared from carbon nanotube-nylon-based composite. , 2005, Nano letters.
[28] M. Barch,et al. Polymeric Micelles Based on Amphiphilic Scorpion-like Macromolecules: Novel Carriers for Water-Insoluble Drugs , 2004, Pharmaceutical Research.
[29] K. Uhrich,et al. Amphiphilic Scorpion-like Macromolecules: Design, Synthesis, and Characterization , 2004 .
[30] M. Brown,et al. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. , 1983, Annual review of biochemistry.